Does OKT3 increase the risk of recurrent hepatitis B in patients transplanted for hepatitis B? [electronic resource]
Producer: 20001222Description: 810-2 p. digitalISSN:- 1527-6465
- DNA, Viral -- analysis
- Graft Rejection -- drug therapy
- Hepatitis B -- surgery
- Hepatitis B Surface Antigens -- analysis
- Hepatitis B virus -- genetics
- Humans
- Immunization, Passive
- Immunoglobulins -- therapeutic use
- Immunosuppressive Agents -- adverse effects
- Liver Transplantation
- Muromonab-CD3 -- adverse effects
- Recurrence
- Risk Factors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.